Epstein Secrets

with prelims on Oct 29 (trading -1.5%) • Lafarge reports EBITDA inline, reiterates FY demand forecast, stock has had good run (trading +0.49%) • Novo Nordisk: FDA panel votes 8-4 to approve new ultra-long-lasting insulin Degludec (trading +8.3%) • IAG reports inline with estimates but FY loss much worse

and $0.25. Secondaries (announced/priced): ARRY, PSLV, PVR, LMI LN (rights), PRGX, LGCY, TUMI, PAA IPO's: N/A Key Research: Janney downgrades DIS, Barcap upgrades HFC & downgrades CTXS, Jeff upgrades MNT/MOH Key Research: Nomura upgrades MMM, Raja initiates ABMD (mp) & upgrades CCOI, Piper cuts MDRX

mith & Nephew soon at 'significant premium" (Bloomberg) • Equinix board approves REIT conversion effective for taxable year beginning Jan 1 2015 • Novo Nordisk (NOVOB DC): Saxenda wins FDA approval to treat obesity (was expected) • HeidelbergCement sells Hanson Building Products unit for $1.4B to Lone Star

K) files for 15.75M shares IPO through Chardan Capital and Maxim Group, Black Knight Financial Services (BKFS) files $100M IPO US Key Research: .' Barcap initiates VA (ow), DB initiates VA (buy), MLB initiates EFC (hold) & HALO (buy) ••• Ladenberg downgrades MMM, Wells initiates ACAT (mp) Europe Key

nd Friday. European markets mostly higher with Spain & Italy underperforming -0.25%. Volumes tracking — 90% of 20day average. In single stock news, Novo Nordisk (NOVOB DC) trading -11.7% after the FDA denied approval of its diabetic drug. SPA's +3 handles = 1515.60 last. "'EU Fin Min meeting today & tomorro

y's) • Stifel upgrades USBNVFC (buy's) & cuts FITB/PDH and CMA/KEY (sell), RBC upgrades AOL ••• KBW upgrades RNST & downgrades PRI and SIAL (sell), Barcap initiates USAC (ow) • Key upgrades KNX/SWFT/HTLD (buy's) Europe Key Research: • Citi downgrade TCG LN, Nomura upgrade ETL FP, JPM upgrade BBVASM,